SBIR/STTR Research Award
Non-Invasive Ventilation Mask With Zero Leakage for Patients With Highly Infectious Diseases
Award amount
$99,945Program and phase
SBIR · Phase IAward year
2021Award details
- Awarding agency
- Department of Defense
- Branch
- Defense Logistics Agency
- Recipient company
- CREARE LLC
- Proposal award date
- 2020-11-20
- Contract end date
- 2021-03-19
- UEI
- JDKYAKDT4TT6
- Solicitation number
- 20.2
- Topic code
- DLA202-011
Research abstract
A large number of patients with viral respiratory diseases such as COVID-19 and SARS require respiratory support. Invasive ventilation is commonly used for these patients, but this requires equipment that is in limited supply in a pandemic and can lead to poor outcomes for many patients. Non-Invasive Ventilation (NIV) via a mask is an appropriate alternative treatment for many patients that can lead to better outcomes. This type of treatment can generally be performed using a CPAP or BiPAP machine, which are very common. However, for COVID-19 and other highly infectious diseases, NIV use is limited due to the risk of disease transmission through contaminated aerosols leaking around the mask seal. In the proposed program, we will develop an innovative mask for use with NIV that will eliminate leakage of contaminated air through the mask seal. This will allow widespread use of NIV therapy during a viral pandemic while protecting health care workers.
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- Improving Signal-to-Noise in Military Boom-Mounted Microphones
- Scratch Removal from Acrylic Windscreens
- A multi-function earplug that measures in-ear noise, standard noise dosimetry and hearing function
- Development of an automated Needle Decompression Device
- MOF Based Adsorbent System for the Removal of CO2
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
- Non-Invasive Ventilation Mask with Zero Leakage for Patients with Highly Infectious Diseases
- Rapid Viral Pandemic Suppression With Molecular Affinity Development
- Extreme Efficiency Nanodroplet Air Filtration
- A New, Simple, Rapid, On-Site Test for Detection of and Prevention from SARS-CoV Viruses
- Novel Spectroscopic Detection of Viral Pathogens in Saliva
Research funding history
1,365 SBIR/STTR records share this UEI (1983–2026). Reported award amounts total $507,020,394. Reported amounts are not federal obligations.
Phases: Phase I, Phase II, Phase II – Direct to Phase II
Agencies: Department of Defense, National Aeronautics and Space Administration, Department of Health and Human Services, Department of Energy, Department of Transportation, Department of Commerce